Assessing the impact of subsequent checkpoint inhibitor (CPI) treatment on overall survival: Post hoc analyses from the phase III JAVELIN Lung 200 study of avelumab vs docetaxel in platinum-treated locally advanced/metastatic non-small cell lung cancer (NSCLC)

Barlesi F., Ozguroglu M., Vansteenkiste J. F., Spigel D., Yang J. C., Bajars M., ...More

44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 27 September - 01 October 2019, vol.30 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 30
  • City: Barcelona
  • Country: Spain
  • Istanbul University Affiliated: Yes